Tafenoquine was used to treat Plasmodium vivax malaria cases who had previously failed
treatment with chloroquine and primaquine. Chloroquine was followed by a loading dose of …

Plasmodium vivax causes debilitating but usually non-lethal malaria in most of Asia and
South America. Prevention of relapse after otherwise effective therapy for the acute attack …

Tafenoquine is being developed for radical cure and post-exposure prophylaxis of
Plasmodium vivax malaria. In an open-label study, 1512 Australian Defence Force …

Background. Tafenoquine is an 8-aminoquinoline developed as a more effective
replacement for primaquine. In a previous dose-ranging study in Thailand, 3 tafenoquine …

A clinical field trial was conducted to determine if mefloquine is effective in the treatment of
malaria due to Plasmodium vivax. Forty patients with P. vivax malaria were treated with …

We studied the antirelapse efficacy of a supervised 14-d 15 mg/d regimen of primaquine
therapy (n= 131) compared with no antirelapse therapy (n= 142) in 273 patients with …

Relapse of Plasmodium vivax malaria following standard primaquine dosing has been
reported from many areas, and more recently from sub-Saharan Africa. In this report we …

To define the current efficacy of Fansidar (F. Hoffmann-La Roche Ltd., Basel Switzerland)(
pyrimethamine and sulfadoxine), primaquine in a high dose, and artesunate for treating …

A study was carried out to investigate the response of patients infected with Plasmodium
vivax (confirmed by peripheral blood film examination) to treatment with primaquine. A total …

The presence of chloroquine-resistant Plasmodium vivax malaria in the New World has
been suspected but not confirmed. We report the cases of three patients who acquired vivax …